Lamotrigine Extended Release Tablets
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D220R0059
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Kyle Lewicki kyle.lewicki@dla.mil (445) 737-0977
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation is for the procurement of Lamotrigine Extended Release (ER) Tablets by the Defense Logistics Agency Troop Support Medical. The solicitation was originally issued under Solicitation SPE2D220R0059 and the resulting contract was awarded to AVKARE LLC located in Pulaski, TN. The contract is for the supply of Lamotrigine ER Tablets with no set-aside designation. Key contract requirements include the ability to provide the tablets in the required quantities and to meet the delivery timeline. The evaluation criteria focus on the contractor's capability to fulfill the contract requirements. The original solicitation was posted on January 16, 2020, and proposals were due on February 25, 2020.
The contract has been subsequently modified multiple times, including the exercise of Option Year 4 which runs from May 13, 2024, through May 12, 2025. The total contract value or budget range is not specified in the documents provided. The place of performance is not explicitly stated, but it can be inferred that the contractor, AVKARE LLC, is responsible for delivering the tablets to the designated locations.
Notice text
10 versions
Update #10 · Latest ·
Modification P00007 SPE2D220D0092 issued to invoke option year 4 for Lamotrigine ER National Contract.
Modification P000006 SPE2D220D0092 to incorporate Drug Supply Chain Act (DSCA) into soliciation for subject contract.
Modification P00005 SPE2D220D0092 to incorporate FAR 52.204-27 Prohibition on a Bytedance covered Application (June 2023) into contract.
Modification P00004 SPE2D220D0092 issued to invoke option year 3 for Lamotrigine ER National Contract.
Modification P00003 SPE2D220D0092 issued to invoke option year 2 for Lamotrigine ER National Contract.
Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract.
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #9 ·
Modification P000006 SPE2D220D0092 to incorporate Drug Supply Chain Act (DSCA) into soliciation for subject contract.
Modification P00005 SPE2D220D0092 to incorporate FAR 52.204-27 Prohibition on a Bytedance covered Application (June 2023) into contract.
Modification P00004 SPE2D220D0092 issued to invoke option year 3 for Lamotrigine ER National Contract.
Modification P00003 SPE2D220D0092 issued to invoke option year 2 for Lamotrigine ER National Contract.
Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract.
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #8 ·
Modification P00004 SPE2D220D0092 issued to invoke option year 3 for Lamotrigine ER National Contract.
Modification P00003 SPE2D220D0092 issued to invoke option year 2 for Lamotrigine ER National Contract.
Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract.
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #7 ·
Modification P00003 SPE2D220D0092 issued to invoke option year 2 for Lamotrigine ER National Contract.
Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract.
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #6 ·
Modification P00002 SPE2D220D0092 issued to invoke option year 1 for Lamotrigine ER National Contract.
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #5 ·
Modification P00001 SPE2D220D0092 is issued to incorporate FAR 52.204-24 and FAR 52.204-25 into subject solicitation.
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #4 ·
Amendment 0003 SPE2D220R0059 dated 02/14/2020 is issued to change the closing date to reflect February 25,2020 at 3:00 PM EST.
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #3 ·
Amendment 0002 SPE2D220R0059 dated 01/31/2020 is issued to correct the solicitation number on page four (4) of subject Request for Proposal Block 9: Submission Instructions to reflect Solicitation Number: SPE2D2-20-R-0059 I/L/L SPE2D2-19-R-0059.
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #2 ·
Amendment 0001 SPE2D220R0059 dated 01/23/2020 issued to update the dates for FAR clauses 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment and 52.212-3, Offeror Representation and Certifications-Commercial Items; and to incorporate clause FAR.204-26 Covered Telecommunications Equipment or Services-Representation into the solicitation.
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Update #1 ·
Solicitation for Lamotrigine ER Tablets SPE2D220R0059.
Attachments
Show all 11
Notice history
| Notice | Type | Posted |
|---|---|---|
| Lamotrigine Extended Release Tablets | Award Notice | |
| Lamotrigine Extended Release Tablets | Solicitation | |
| Lamotrigine Extended Release Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity